个体化驱动压导向呼气末正压用于术后呼吸衰竭风险患者(IMPROVE-2):多中心实用性随机临床试验
IMPROVE-2为法国22家医院开展的多中心、实用性、评估者盲法随机试验,纳入急诊腹部手术成人患者,1:1分配至初始肺复张后以驱动压<13 cmH2O为目标个体化调整最高PEEP的干预组,或固定PEEP 5 cmH2O的对照组。主要终点为30天内术后呼吸衰竭复合终点(脱机失败或再插管/治疗性无创通气复合)或全因死亡。干预组87/338(25.7%) vs 对照组69/341(20.2%)发生主要终点(差异5.5%,95%CI -0.8至11.8;RR 1.27,95%CI 0.96-1.68;P=0.08),未达统计学显著。差异主要源于干预组再插管或治疗性无创通气增加(差异7.1%,95%CI 2.5-11.9;RR 1.97,95%CI 1.24-3.11;P=0.004)。结论:该策略未减少术后呼吸衰竭或死亡。
要点
- 急诊腹部手术后呼吸衰竭风险患者中,驱动压<13 cmH2O导向个体化最高PEEP vs 固定PEEP 5 cmH2O,主要终点25.7% vs 20.2%(RR 1.27,95%CI 0.96-1.68;P=0.08),未达统计学显著。
- 干预组再插管或治疗性无创通气发生率较对照组升高(差异7.1%,95%CI 2.5-11.9;RR 1.97,95%CI 1.24-3.11;P=0.004)。
- 其他次要终点两组无差异。
- 作者结论:以驱动压<13 cmH2O为目标个体化调高PEEP未减少术后呼吸衰竭或死亡。
适用人群与场景
- 法国22家医院成年急诊腹部手术患者,存在术后呼吸衰竭风险,机械通气中。
处置流程与药物剂量
- 干预组:初始肺复张后,以驱动压<13 cmH2O为目标个体化调整最高PEEP。
- 对照组:固定PEEP 5 cmH2O。
研究设计与关键结果
- 多中心、实用性、评估者盲法随机试验,纳入急诊腹部手术成人患者,干预组338例、对照组341例。
- 主要终点(30天内术后呼吸衰竭复合终点或全因死亡):干预组87/338(25.7%) vs 对照组69/341(20.2%),差异5.5%(95%CI -0.8至11.8),RR 1.27(95%CI 0.96-1.68),P=0.08。
- 再插管或治疗性无创通气:干预组较对照组增加,差异7.1%(95%CI 2.5-11.9),RR 1.97(95%CI 1.24-3.11),P=0.004。
- 其他次要终点两组无差异。
证据类型、等级与局限
- 证据类型:多中心、实用性、评估者盲法随机临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在急诊腹部手术后呼吸衰竭风险患者中,以驱动压<13 cmH2O为目标个体化调高PEEP的策略未减少术后呼吸衰竭或死亡,且再插管或治疗性无创通气增加。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Airway driving pressure has garnered considerable attention for lung-protective ventilation. We evaluated the clinical effectiveness of airway driving pressure as a target to individualize positive-end-expiratory pressure (PEEP) setting in mechanically ventilated patients at risk for postoperative respiratory failure.
METHODS: We conducted a multicenter, pragmatic, assessor-masked, randomized trial among adult patients undergoing emergency abdominal surgery in 22 hospitals in France. Patients were assigned 1:1 to receive individually adjusted highest PEEP targeting a driving pressure < 13 cmH2O after an initial recruitment maneuver (intervention group) or to a fixed PEEP level of 5 cmH2O (control group). The primary outcome was a composite of postoperative respiratory failure (failure to wean from the ventilator or the composite of reintubation or curative non-invasive ventilation) or all-cause mortality at 30 days. Secondary outcomes included components of the composite primary outcome.
RESULTS: The primary outcome occurred in 87 out of 338 (25.7%) intervention patients and in 69 out of 341 (20.2%) control patients (difference, 5.5%; 95% confidence interval [CI] - 0.8 to 11.8; relative risk, 1.27; 95%CI 0.96-1.68; p = 0.08). The difference was primarily due to an increased incidence of reintubation or need for curative non-invasive ventilation among intervention patients (difference, 7.1%; 95% CI 2.5-11.9; relative risk, 1.97; 95% CI 1.24-3.11; p = 0.004). Other secondary outcomes did not differ.
CONCLUSION: Among patients at risk for postoperative respiratory failure after emergency abdominal surgery, a strategy of individually adjusted highest PEEP in targeting driving pressure lower than 13 cmH2O did not reduce postoperative respiratory failure or death.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03987789.
参考来源
- Futier E, De Jong A, Cirenei C, et al. Personalized driving pressure-guided positive end-expiratory pressure in patients at risk of postoperative respiratory failure (IMPROVE-2): a multicenter, pragmatic, randomized clinical trial. Intensive Care Med. 2025. PMID: 40839096. doi:10.1007/s00134-025-08082-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。